ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
11,370
Employees11,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
11,370
Employees11,370

RMD Key Statistics

Market cap
32.59B
Market cap32.59B
Price-Earnings ratio
23.02
Price-Earnings ratio23.02
Dividend yield
0.97%
Dividend yield0.97%
Average volume
1.29M
Average volume1.29M
High today
$250.01
High today$250.01
Low today
$230.72
Low today$230.72
Open price
$245.01
Open price$245.01
Volume
2.44M
Volume2.44M
52 Week high
$277.67
52 Week high$277.67
52 Week low
$180.27
52 Week low$180.27

Stock Snapshot

As of today, ResMed(RMD) shares are valued at $231.72. The company's market cap stands at 32.59B, with a P/E ratio of 23.02 and a dividend yield of 0.97%.

On 2026-10-30, ResMed(RMD) stock moved within a range of $230.72 to $250.01. With shares now at $231.72, the stock is trading +0.4% above its intraday low and -7.3% below the session's peak.

Trading activity shows a volume of 2.44M, compared to an average daily volume of 1.29M.

Over the past 52 weeks, ResMed(RMD) stock has traded between a high of $277.67 and a low of $180.27.

Over the past 52 weeks, ResMed(RMD) stock has traded between a high of $277.67 and a low of $180.27.

RMD News

Zacks 7h
ResMed Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended September 2026, ResMed (RMD Quick QuoteRMD - Free Report) reported revenue of $1.41 billion, up 5.9% over the same period last year....

ResMed Reports Q1 Earnings: What Key Metrics Have to Say
Investing.com 8h
Needham reiterates Hold on ResMed stock amid GLP-1 drug risks - Investing.com

...

Needham reiterates Hold on ResMed stock amid GLP-1 drug risks - Investing.com
Zacks 3d
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in t...

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Analyst ratings

60%

of 30 ratings
Buy
60%
Hold
30%
Sell
10%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.